GGrantIndex
Sort

64,565 grants matching drug discovery

New Therapies for Liver Fibrosis and Hyperproliferation in Alpha1-AT Deficiency

$1,876,851
David H Perlmutter · Washington University · P01 · FY2022 · DK

Depression susceptibility genes and networks: expression, eQTL and GWAS analysis

$1,876,781
Douglas Frederick Levinson · Stanford University · RC2 · FY2009 · MH

Genetic variant-based drug discovery targeting conserved pathways of aging

$1,876,472
Jan No Middle Name Vijg · Albert Einstein College Of Medicine · U19 · FY2020 · AG

University of New Mexico Cancer Center Support

$1,876,081
Cheryl L Willman · University Of New Mexico Health Scis Ctr · P30 · FY2014 · CA

Integrative Oncogenomics of Multiple Myeloma

$1,875,926
Nikhil C. Munshi · Dana-Farber Cancer Inst · P01 · FY2013 · CA

Novel integrative imaging genetics analysis for Alzheimer's disease riskand progression

$1,874,912
Yize Zhao · Yale University · RF1 · FY2021 · AG

Alzheimer's Disease Core Center

$1,874,582
Thomas M Wisniewski · New York University School Of Medicine · P30 · FY2018 · AG

Vanderbilt NCDDDG for Discovery of Novel Treatments for Schizophrenia

$1,874,484
P Jeffrey Conn · Vanderbilt University · U01 · FY2011 · MH

CENTER FOR PROTEIN STRUCTURE AND FUNCTION

$1,874,433
University Of Arkansas At Fayetteville · P20 · FY2000 · RR

Targeting RNA Binding and Nuclear Export of HIV Rev

$1,873,090
Scripps Research Institute · P01 · FY2003 · GM

Biology and Novel Therapeutics of Cardiovascular Peptides

$1,872,916
John C Burnett · Mayo Clinic Rochester · P01 · FY2014 · HL

Alzheimer's Disease Core Center

$1,871,900
Thomas M Wisniewski · New York University School Of Medicine · P30 · FY2017 · AG

IGF::OT::IGF "HUMANIZED MOUSE MODELS FOR HIV THERAPEUTICS DEVELOPMENT"

$1,871,804
Cheryl Stoddart · University Of California, San Francisco · N01 · FY2016 · AI

Innovative technologies to transform antibiotic discovery. Project 1 Genomic applications to transform Gram-negative Antibiotic discovery

$1,870,233
Deborah T Hung · Broad Institute, Inc. · U19 · FY2021 · AI

Biomolecular Structure and Mechanism, Structure-Based Drug Design

$1,870,126
Xinhua Ji · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Discovery of an Orexin-1 receptor antagonist for treatment of cocaine addiction and dependence

$1,869,612
Fiona Marshall · Heptares Therapeutics, Ltd · R01 · FY2016 · DA

Integrative-omics and Systems Biology across the atopic march

$1,869,376
Rasika Mathias · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

Cannabinoid-based therapy and approaches to quantify pain in sickle cell disease

$1,869,191
Kalpna Gupta · University Of Minnesota · U01 · FY2016 · HL

Automated Cell Culture System

$1,869,146
Robert Damoiseaux · University Of California Los Angeles · S10 · FY2025 · OD

Genetics of Parkonsonism

$1,868,351
Jeffery M. Vance · University Of Miami School Of Medicine · P50 · FY2011 · NS

microRNA-based and novel molecular therapeutics in thoracic cancers

$1,867,997
Chuong Hoang · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Informed Combination Strategies for Peripheral T-cell Lymphomas

$1,867,112
David Marc Weinstock · Dana-Farber Cancer Inst · P01 · FY2019 · CA

Pharmacogenomic Evaluation of Antihypertensive Responses

$1,867,074
Julie A. Johnson · University Of Florida · U01 · FY2006 · GM

Centers for Intervention Development and Applied Research (CIDAR)

$1,866,652
William T. Carpenter · University Of Maryland Baltimore · P50 · FY2011 · MH

Starve and Kill: Engineered Antigens Targeting Nutrient Acquisition Pathways Essential for Gonococcal Infection and Disease

$1,866,512
Cynthia Nau Cornelissen · Georgia State University · U19 · FY2021 · AI